# ATEM (Alvesco Non-interventional Study)

> **NCT01147224** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 400 (estimated)

## Conditions studied

- Asthma
- Allergy

## Interventions

- **DRUG:** Alvesco

## Key facts

- **NCT ID:** NCT01147224
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-08
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147224, "ATEM (Alvesco Non-interventional Study)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01147224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*